How a Prior Auth Appeal Gets Reviewed

Your doctor submits a request for a medication you've been taking for two years. A week later, a letter arrives: denied. The insurer says the drug isn't "medically necessary" — a phrase that feels absurd given your history. Your doctor files an appeal. Then nothing happens for days. You call the insurer and wait on hold. You're not sure who is reading anything, or whether anyone is reading anything at all.

The prior authorization appeal process is one of the most opaque corners of the American healthcare system. Patients and even some providers experience it as a black box: paperwork goes in, a decision eventually comes out, and what happens in between is rarely explained. Frustration is common, and often warranted — but the confusion is partly structural.

This article explains what actually happens inside an insurer's review pipeline after an appeal is filed: who looks at it, what criteria they apply, and why the process is built the way it is.

What the Prior Authorization Appeal System Is Meant to Do

Prior authorization itself exists as a cost and utilization management tool. Insurers require advance approval for certain treatments, drugs, or procedures to verify that the service meets clinical criteria before they agree to pay. As explained in how prior authorization systems work, the process is designed to catch cases where a less expensive or lower-risk alternative might serve the patient equally well. The appeal layer is the built-in correction mechanism for when that initial screening gets it wrong.

Regulators — both federal and state — require insurers to offer at least one level of internal appeal and, in most cases, access to an external independent review. The appeal system is meant to ensure that a single reviewer's decision, or a rigid algorithmic check, isn't the final word. It creates a structured second look, theoretically with more clinical context and a higher level of expertise than the original determination received.

How a Prior Auth Appeal Actually Works in Practice

When a provider or patient submits an appeal, it enters an intake queue at the insurer's utilization management (UM) department. A UM coordinator — typically a nurse or administrative specialist — logs the case, assigns it a tracking number, and checks it for completeness. Missing documents, such as clinical notes, lab results, or a letter of medical necessity from the treating physician, are flagged immediately. Incomplete submissions are often returned or put on hold, which is one of the most common causes of delay. The clock on the insurer's response deadline doesn't always start until the file is considered complete.

Once the file is complete, it moves to clinical review. For straightforward cases, a UM nurse reviewer applies the insurer's clinical criteria — typically drawn from evidence-based guidelines published by organizations like InterQual or MCG (formerly Milliman Care Guidelines). The reviewer checks whether the submitted documentation satisfies specific criteria: diagnosis codes, prior treatment history, documented failure of alternatives, and clinical indicators. If the case clearly meets criteria, it can be approved at this stage. If it doesn't, or if the case is complex, it escalates to a physician reviewer — a medical doctor employed by or contracted with the insurer, who must be board-certified in a relevant specialty for cases involving that specialty under federal rules established by the Affordable Care Act.

The physician reviewer reads the clinical record, applies the criteria, and issues a determination. They may also attempt a peer-to-peer call — a direct conversation with the treating physician — which can significantly affect the outcome. If the appeal is denied again, the patient and provider receive a written explanation citing the specific criteria not met. At that point, most plans offer a second-level internal appeal and, after that, access to an Independent Review Organization (IRO): a state-certified third party with no financial relationship to the insurer, whose decision is typically binding on the plan.

Why the Appeal Process Feels Slow, Rigid, or Frustrating

The timelines feel bureaucratic because they largely are — by design. Regulatory frameworks set maximum response windows (72 hours for urgent appeals, 30 days for standard ones under many state and federal rules), but those are ceilings, not targets. Insurers manage high volumes of cases simultaneously, and each one moves through a sequential queue. A file that arrives incomplete, or that requires a specialist reviewer who isn't immediately available, can sit at a stage for days without any visible movement from the patient's perspective. The process resembles other document-heavy administrative pipelines — not unlike how a zoning variance request works its way through layers of review before reaching a decision-maker with authority.

The rigidity of clinical criteria is also a structural feature, not an accident. Standardized guidelines are meant to make decisions consistent and defensible. But they're written at a population level, and individual patients sometimes fall outside the patterns the criteria were built around. When a patient's clinical situation is genuinely unusual, the criteria-based system has limited flexibility — the documentation has to make the case that the exception is medically justified, which puts significant burden on the treating physician to frame the record in the right language.

What People Misunderstand About Prior Auth Appeals

A common belief is that appeals are rarely successful and mostly performative. The data doesn't fully support this. Studies and government reports — including analyses from the Kaiser Family Foundation — have found that when patients appeal denied claims, they win a significant portion of the time, sometimes more than 40% of internal appeals and an even higher share at the independent review stage. The system is not designed to be impenetrable. The larger problem is that most denials are never appealed at all, often because patients don't know they have the right or don't have the support to navigate the process.

Another misconception is that the physician reviewer making the final call has no relevant expertise. Federal law — specifically ACA provisions and ERISA regulations — requires that adverse determinations on clinical appeals be made by a clinician with appropriate expertise, and that independent reviewers be board-certified specialists when the case involves a specialty service. The reviewer may still reach a different conclusion than the treating physician, but it isn't accurate to say no qualified medical judgment is involved. The disagreement is often genuinely clinical, not simply administrative.

The prior authorization appeal process is a structured, multi-stage review system with defined roles, regulatory requirements, and escalation paths. It is slow and often frustrating, but it is not arbitrary. Understanding its mechanics — intake, clinical review, physician determination, and independent oversight — helps patients and providers engage with it more effectively.

Note: This article is for informational purposes only and is not a substitute for professional advice. If you need guidance on specific situations described in this article, consider consulting a qualified professional.